Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $848.8100 (1%) ($838.1650 - $848.8100) on Mon. Dec. 11, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.1% (three month average) | RSI | 74 | Latest Price | $848.8100(1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.6% a day on average for past five trading days. | Weekly Trend | REGN advances 2.5% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) SDY(66%) JETS(59%) XLU(59%) IBB(58%) SPLV(56%) | Factors Impacting REGN price | REGN will decline at least -0.55% in a week (0% probabilities). VXX(-42%) USO(-40%) XLE(-39%) UNG(-38%) VIXM(-30%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.55% (StdDev 1.1%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $838.96(1.17%) | 10 Day Moving Average | $827.4(2.59%) | 20 Day Moving Average | $813(4.4%) | To recent high | -0% | To recent low | 9.5% | Market Cap | $89.998b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |